Inhaled nitric oxide and high concentrations of oxygen in pediatrics patients with congenital cardiopathy and pulmonary hypertension
report of five cases
Keywords:
Nitric Oxide, Pulmonary Hypertension, Congenital CardiopathyAbstract
Five patients with ages ranging from 6 months to 3 years were analyzed. All received inhaled nitric oxide (NO - 20 parts per million (ppm) ) and oxygen (0(2) - at a concentration of 90-95%) by means of an oxygen hood. Mean Pulmonary Artery Pressure (MPAP), Mean Aortic Pressure (MAoP), Pulmonary Vascular Resistance (PVR) and Systemic Vascular Resistance (SVR) were measured and the calculation of their relationship to pulmonary/systemic flow (Qp/Qs) was performed by the catheterization' of the femoral artery vein. Three patients presented reduction in PVR and increase in Qp/Qs. There were no systemic alterations or any side effect from using NO.
Downloads
References
Hopkins R, Bull C, Haworth S et al. Pulmonary hypertensive crises following surgery for congenital heart defects in young children. Eur J Cardiothorac Surg 1991; 5: 628-34.
Pepke-Zaba J, Higenbottam TW, Dinh-Xuan A et al. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet, 1991; 338:1173-74.
Schranz D, Huth R, Wippermann F et al. Nitric oxide and prostacyclin lower suprasystemic pulmonary hypertension after cardiopulmonary bypass. Eur J Pediatr 1993;152: 793-96.
Frostell C, Blomqvist H, Zapol W. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilatation. Anesthesiology 1993; 78: 427-35.
Roberts Jr JD, Lang P, Bigatello ML et al. Inhaled nitric oxide in congenital heart disease. Circulation 1993; 87 (2): 447-53.
Niosh. Recommendations for occupational Safety and Health standards. MMWR Morb Mortal Wkly Rep 1988; 37(suppl 7):1-29.
Finner NN, Etches PC, Kamstra B et al. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: .dose response. J Pediatr 1994;124: 302-8.
Journois D, Pouard P, Mauriat P et al. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 1994; 107(4):1129-35.
Miller OJ, Celemajer DS, Deanfield JE et al. Very low dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J. Thorac Cardiovasc Surg 1994;108:487-94.
Meneghini R. A toxicidade do oxigênio. Ciência Hoje 1987; 5:57-52.
